ArticleJournal of thoracic disease2018

Programmed cell death protein-1/programmed death-ligand 1 blockade enhances the antitumor efficacy of adoptive cell therapy against non-small cell lung cancer.

Jingyi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.